Le Lézard
Classified in: Health
Subject: RCL

CPSC Warns Consumers to Stop Use of Three Models of Adult Portable Bed Rails Manufactured by Bed Handles, Inc., Due to Entrapment, Asphyxia Hazard


WASHINGTON, April 29, 2021 /PRNewswire/ -- https://www.cpsc.gov/Newsroom/News-Releases/2021/CPSC-Warns-Consumers-to-Stop-Use-of-Three-Models-of-Adult-Portable-Bed-Rails-Manufactured-by-Bed-Handles-Inc-Due-to-Entrapment-Asphyxia-Hazard

The U.S. Consumer Product Safety Commission (CPSC) is warning consumers to immediately stop using three models of adult portable bed rails manufactured by Bed Handles, Inc.  These models (AJ1, BA10W, and BA11W) can create an entrapment hazard and pose a risk of asphyxia to users.

Because the manufacturer of these bed rails is no longer in business, the company cannot offer a remedy.  Consumers are urged to immediately stop use of the products and dispose of the products.

CPSC evaluated the bed rails and found that they can allow an individual to become entrapped between the bed rail and mattress, or within the portions of the bed rail itself, leading to asphyxia.  

These bed rails have been sold online at Walmart.com, MedontheGo.com, soymedical.com, bpimedicalsupply.com, sonomasurgical.com, and other online retailers for around $80 to $100.  The products have also been found for sale on secondary sites, such as eBay.com.  The model number can be found on a white label located on the bottom of the handle.

The CPSC announced a recall of a previous version of the bed rails in both 2014 and 2015, due to an entrapment hazard.  These bed rails, manufactured between 1994 and 2007, were sold without retention straps.  Four people died after becoming entrapped in the bed rail; all four victims were elderly or disabled individuals.  Since 2007, the bed rails have been sold with retention straps, but CPSC has found that the straps do not adequately protect consumers.

CPSC urges consumers to stop using these bed rails and report any related incidents to the agency at www.SaferProducts.gov.

About the U.S. CPSC
The U.S. Consumer Product Safety Commission (CPSC) is charged with protecting the public from unreasonable risks of injury or death associated with the use of thousands of types of consumer products.  Deaths, injuries, and property damage from consumer product incidents cost the nation more than $1 trillion annually.  CPSC's work to ensure the safety of consumer products has contributed to a decline in the rate of deaths and injuries associated with consumer products over the past 40 years.

Federal law bars any person from selling products subject to a publicly announced voluntary recall by a manufacturer or a mandatory recall ordered by the Commission.

For lifesaving information:
- Visit CPSC.gov.
- Sign up to receive our e-mail alerts.
- Follow us on Facebook, Instagram @USCPSC and Twitter @USCPSC
- Report a dangerous product or a product-related injury on www.SaferProducts.gov.
- Call CPSC's Hotline at 800-638-2772 (TTY 301-595-7054).
- Contact a media specialist.

Release Number: 21-122

SOURCE U.S. Consumer Product Safety Commission


These press releases may also interest you

at 20:14
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 19:30
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ("agilon" or the "Company").  This action, captioned Hope v. agilon health, inc., et...

at 18:00
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market.  The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG...

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...



News published on and distributed by: